![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status |
Youngjoo Lee, Ji-Youn Han, Sung Ho Moon, Byung-Ho Nam, Kun Young Lim, Geon Kook Lee, Heung Tae Kim, Tak Yun, Hye Jin An, Jin Soo Lee |
Cancer Research and Treatment. 2017;49(4):981-989. Published online 2017 January 6 DOI: https://doi.org/10.4143/crt.2016.522 |
Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): from cisplatin alone to cisplatin + etoposide Chemoradiotherapy for stage III non-small cell lung cancer Neoadjuvant chemoradiotherapy for stage III non-small cell lung cancer Concurrent chemoradiotherapy followed by surgery for advanced stage III non-small cell lung cancer (NSCLC) A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer Irinotecan/Cisplatin versus Vindesine/Cisplatin versus Irinotecan Alone in Advanced Non–Small-Cell Lung Cancer A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma |
This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014. |